Cargando…
Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy
BACKGROUND: Doxorubicin (Dox) is a chemotherapy drug with limited application due to cardiotoxicity that may progress to heart failure. This study aims to evaluate the role of cardiomyocytes derived from mouse embryonic stem cells (CM-mESCs) in the treatment of Dox-induced cardiomyopathy (DIC) in mi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799903/ https://www.ncbi.nlm.nih.gov/pubmed/29402309 http://dx.doi.org/10.1186/s13287-018-0788-2 |